BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34199418)

  • 1. Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor.
    Lee J; Avramets D; Jeon B; Choo H
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Activity Relationships and Therapeutic Potentials of 5-HT
    Modica MN; Lacivita E; Intagliata S; Salerno L; Romeo G; Pittalà V; Leopoldo M
    J Med Chem; 2018 Oct; 61(19):8475-8503. PubMed ID: 29767995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons.
    Speranza L; Labus J; Volpicelli F; Guseva D; Lacivita E; Leopoldo M; Bellenchi GC; di Porzio U; Bijata M; Perrone-Capano C; Ponimaskin E
    J Neurochem; 2017 Jun; 141(5):647-661. PubMed ID: 28122114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.
    De Filippis B; Nativio P; Fabbri A; Ricceri L; Adriani W; Lacivita E; Leopoldo M; Passarelli F; Fuso A; Laviola G
    Neuropsychopharmacology; 2014 Oct; 39(11):2506-18. PubMed ID: 24809912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder.
    Lacivita E; Niso M; Mastromarino M; Garcia Silva A; Resch C; Zeug A; Loza MI; Castro M; Ponimaskin E; Leopoldo M
    ACS Chem Neurosci; 2021 Apr; 12(8):1313-1327. PubMed ID: 33792287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment.
    Lee A; Choo H; Jeon B
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome.
    Valenti D; de Bari L; Vigli D; Lacivita E; Leopoldo M; Laviola G; Vacca RA; De Filippis B
    Neuropharmacology; 2017 Jul; 121():79-88. PubMed ID: 28419872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date.
    Nikiforuk A
    CNS Drugs; 2015 Apr; 29(4):265-75. PubMed ID: 25721336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical update on the potential for serotonin 5-HT
    Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J
    Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders.
    Crider A; Pillai A
    J Pharmacol Exp Ther; 2017 Jan; 360(1):48-58. PubMed ID: 27789681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.
    Canal CE; Felsing DE; Liu Y; Zhu W; Wood JT; Perry CK; Vemula R; Booth RG
    ACS Chem Neurosci; 2015 Jul; 6(7):1259-70. PubMed ID: 26011730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting 5-HT receptors for the treatment of obesity.
    Sargent BJ; Henderson AJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serotonin receptors in the action of atypical antipsychotic drugs.
    Meltzer HY; Massey BW
    Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and Therapeutic Potential of the 5-HT
    Blattner KM; Canney DJ; Pippin DA; Blass BE
    ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-HT-7 receptor ligands on memory and cognition.
    Zareifopoulos N; Papatheodoropoulos C
    Neurobiol Learn Mem; 2016 Dec; 136():204-209. PubMed ID: 27780766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders.
    Benachenhou S; Laroui A; Dionne O; Rojas D; Toupin A; Çaku A
    Int Rev Neurobiol; 2023; 173():115-139. PubMed ID: 37993175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
    Pranzatelli MR
    Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminotriazines with indole motif as novel, 5-HT
    Kułaga D; Jaśkowska J; Satała G; Latacz G; Śliwa P
    Bioorg Chem; 2020 Nov; 104():104254. PubMed ID: 32919133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology.
    Kvachnina E; Liu G; Dityatev A; Renner U; Dumuis A; Richter DW; Dityateva G; Schachner M; Voyno-Yasenetskaya TA; Ponimaskin EG
    J Neurosci; 2005 Aug; 25(34):7821-30. PubMed ID: 16120784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Membranes of Human SH-SY5Y Neuroblastoma Cells Express Serotonin 5-HT
    Tempio A; Niso M; Laera L; Trisolini L; Favia M; Ciranna L; Marzulli D; Petrosillo G; Pierri CL; Lacivita E; Leopoldo M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.